Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
The Effect of Oral Administration of Alendronate on Knee Functions Following Anterior Cruciate Ligament Reconstruction
NCT05527548Phase 4Recruiting
- Sponsor
- The Chinese University of Hong Kong
- Start
- Dec 2022
- Primary completion
- Jul 2028
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 4, randomised, double-blind trial of alendronate in anterior cruciate ligament injury (2 arms), sponsored by The Chinese University of Hong Kong. Primary endpoint: Single-leg Hop Test at 12 months. Started Dec 2022; status: recruiting.
02
Drugs
alendronate
03
Conditions
anterior cruciate ligament injury
Beyond the preview
Go deeper on NCT05527548.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT05527548.